ORAL LEUKOPLAKIA
Clinical trials for ORAL LEUKOPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ORAL LEUKOPLAKIA trials appear
Sign up with your email to follow new studies for ORAL LEUKOPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug metformin shows promise in stopping oral cancer before it starts
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions like leukoplakia or erythroplakia. About 26 participants took metformin to see if it could shrink or eliminate these lesions. The goal is to stop cancer…
Matched conditions: ORAL LEUKOPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 07:34 UTC
-
Can a diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent oral cancer in people with precancerous white or red patches in the mouth. 34 adults with these patches took metformin to see if it could reverse or stop the growth of abnormal cells. The goal is to find a sa…
Matched conditions: ORAL LEUKOPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated May 22, 2026 14:01 UTC